Streptozotocin for malignant insulinomas and carcinoid tumor. Report of eight cases and review of the literature.
D007516:Adenoma, Islet Cell / Q000188:drug therapy*; D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D002276:Carcinoid Tumor / Q000188:drug therapy*; D056486:Chemical and Drug Induced Liver Injury; D003404:Creatinine / Q000378:metabolism; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007328:Insulin / Q000097:blood; D007668:Kidney; D007677:Kidney Function Tests; D008099:Liver; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D011384:Proinsulin; D011507:Proteinuria; D011877:Radionuclide Imaging; D012075:Remission, Spontaneous; D013311:Streptozocin / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D013997:Time Factors; D014044:Tolbutamide
D001786:Blood Glucose; D007328:Insulin; D013311:Streptozocin; D011384:Proinsulin; D014044:Tolbutamide; D003404:Creatinine